Vyepti

Vyepti

Manufacturer:

Lundbeck Export A/S
Concise Prescribing Info
Contents
Eptinezumab
Indications/Uses
Prophylaxis of migraine in adults.
Dosage/Direction for Use
100 mg by IV infusion every 12 wk. May be administered as 300 mg by IV infusion every 12 wk.
Contraindications
Special Precautions
Discontinue if serious hypersensitivity reactions occur. Pregnancy & lactation.
Adverse Reactions
Nasopharyngitis, hypersensitivity reactions.
MIMS Class
Antimigraine Preparations
ATC Classification
N02CD05 - eptinezumab ; Belongs to the class of calcitonin gene-related peptide (CGRP) antagonists preparations. Used to relieve migraine.
Presentation/Packing
Form
Vyepti infusion conc 100 mg/mL
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in